Expression of p63, bcl-2, bcl-6 and p16 in Basal Cell Carcinoma andSquamous Cell Carcinoma of the Skin
Expression of p63, bcl-2, bcl-6 and p16 in Basal Cell Carcinoma and Squamous Cell Carcinoma of the Skin
2
조회
0
다운로드
3
인용
0
참고문헌
초록
Abstract
Background : Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are the common malignant neoplasms of the skin. The p63 is a p53 homologue which is considered to be a reliable keratinocyte stem cell marker. Bcl-2 plays a key role in cell longevity by preventing apoptosis, whereas the bcl-6 gene functions as a transcriptional repressor. The p16-CDK4/6 complex arrests the cell cycle at G0/G1 phase. In the present study, the expression of p63, bcl-2, bcl-6, and p16 in BCC and SCC was evaluated. Methods : Forty-seven BCCs and 43 SCCs were selected and microarrayed in paraffin blocks. Immunohistochemical analysis was performed with specific antibodies for bcl-2, bcl-6, p16 and p63. Results : p63 was found to be expressed in all BCCs and SCCs. Bcl-2 was exclusively expressed in BCCs (100%), but there was negative expression in SCCs, whereas bcl-6 was positively expressed in 18.2% of SCCs, and was negative in BCCs. In SCCs, p16 was expressed at high frequency (47.7%) than in BCCs (14.9%). The expression of p16 was correlated with the histologic grades of SCCs. Conclusion : The different patterns of bcl-2, bcl-6, p63 and p16 protein expression between BCCs and SCCs may represent the different histogenesis and morphologic features of two lesions
참고문헌 (30)
- "The p53 gene family", 18, pp.7701~5 (1999)
- "p63 expression profiles inhuman normal and tumor tissues", 8, pp.494~501 (2002), Clin Cancer Res
- "Distribution of p63,cytokeratins 5", 6 and cytokeratin 14 in 51normal and 400 neoplastic human tissue samples using TARP-4multi-tumor tissue microarray, 2003, pp.443, 122~32
- "Taking advantage of basic research:p63is a reliable myoepithelial and stem cell marker", 9, pp.280~9
- "p63 expression in normal human epidermis and epidermalappendages and their tumors", 30, pp.11~7 (2003)
- "Cloning the chromosomalbreakpoint of t clustering around JH onchromosome 14 and near a transcriptional unit on 18", 41, pp.899~906
- "Bcl-2 is an inner mitochondrial membrane protein that blocks programmedcell death", 348, pp.334~6 (1990)
- "Role of BCL-2 in thesurvival and function of developing and mature sympathetic neurons", 15, pp.649~61 (1995)
- "Bcl-2 expression in adultand embryonic non-haematopoietic tissues", 169, pp.431~7 (1993)
- "Bcl-2expression in primary malignancies of the skin", 131, pp.909~12 (1995)
- "Transcriptional repressionby the proto-oncogene BCL-6", 12, pp.2331~42 (1996)
- "BCL-6 protein is expressedin germinal center B cells", 86, pp.45~53 (1995)
- "The expression ofbcl-2 and bcl-6 protein in normal and malignant transitional epithelium", 31, pp.272~5 (2003)
- "The BCL-6 gene is predominantlyexpressed in keratinocytes at their terminal differentiation stage", 228, pp.216~20 (1996)
- "Expressionof bcl-6 protein in normal skin and epidermal neoplasms", 47, pp.600~7 (1997)
- "Differential expression and cell cycleregulation of the cyclin-dependent kinase 4 inhibitor p16Ink4", 54, pp.5816~20 (1994)
- "Loss of expression of the p16gene is frequent in malignant skin tumors", 230, pp.85~8 (1997)
- "Immunohistochemical comparison of p16expression in actinic keratoses and squamous cell carcinomas of theskin", 15, pp.1121~5 (2002)
- "Overexpression of p16INK4Aas a specific marker for dysplastic and neoplastic epithelial cells ofthe cervix uteri", 92, pp.276~84 (2001)
- "Biology of basal cell carcinoma", pp.161~75
- "Dermatology in General Medicine", pp.737~47 (2003), McGraw-Hill Press
- "DeltaNp63alpha and TAp63alpharegulate transcription of genes with distinct biological functions incancer and development", 63, pp.2351~7 (2003)
- "Differential expression ofp63 isoforms in normal tissues and neoplastic cells", 198, pp.417~27 (2002)
- "Bcl-2 expressionreliably distinguishes trichoepitheliomas from basal cell carcinomas", 131, pp.28~31 (1994)
- "Bcl-2 expressionin epidermal keratinocytic diseases", 74, pp.1720~4 (1994)
- "Aberrant bcl-2 protein expression provides a possiblemechanism of neoplastic cell growth in cutaneous basal-cellcarcinoma", 21, pp.398~403 (1994)
- "Expression of the bcl-2 oncogene protein is not specific for the 14;18chromosomal translocation", 137, pp.225~32 (1990)
- "Differential expressionof the bcl-2 oncogene in human basal cell carcinoma", 27, pp.355~9
- "Progression in cutaneous malignantmelanoma is associated with distinct expression profiles:a tissuemicroarray-based study", 164, pp.193~203 (2004)
- "P16 and p53 expressionin(pre)malignant epidermal tumors of renal transplant recipientsand immunocompetent individuals", 16, pp.869~78 (2003)
